Skip To Content
 

Search:

 

Diagnostic Imaging Pathways - HCC Risk Factors Present
PathwaysHome
Flow Chart
Image gallery
Teaching Points
References
PDF Version

References

  1. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Disease.Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236. (Review Article) Click here to view reference
  2. Leslie DF, Johnson CD, MacCarty RL, et al. Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular matastases. AJR Am J Roentgenol 1995;165:1403-6. (Level III evidence)
  3. Yamashita Y, Ogata I, Urata J, et al. Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings. Radiology 1997;203:121-6. (Level III evidence)
  4. Szklaruk J, Silverman PM, Charnsangavej C. Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma. AJR Am J Roentgenol 2003;180:441-54. (Review article)
  5. Angelelli G, Ianora AAS, Scardapane A, et al. Role of computerized tomography in the staging of gastrointestinal neoplasms. Semin Surg Oncol 2001;20:109-21. (Review article)
  6. Lim JH, Choi D, Kim SH, et al. Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. AJR Am J Roentgenol 2002;179:67-73. (Level II evidence). Click here to view reference
  7. Whitney WS, Herfkens RJ, Jeffrey RB, et al. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic haemangiomas from malignancies at 1.5T. Radiology 1993;189:863-70. (Level III evidence)
  8. Rode A, Bancel B, Douek P, et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001;25:327-36. (Level II evidence). Click here to view reference
  9. Libbrecht L, Bielen D, Verslype C, et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002;8:749-61. (Level III evidence)
  10. Debelke D, Martin WH, Sandler MP, Chapman WC, Wright K Jnr, Pinson CW. Evaluation of Benign vs Malignant Hepatic Lesions With Positron Emission Tomography. Arch Surg 1998;133:510-6. (Level II evidence). Click here to view reference
  11. Kurtaran A, Becherer A, Pfeffel F, Muller C, Traub T, Schmaljohann J, et al. 18F-Fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver. Liver 2000;20:487-90. (Level IV evidence)
  12. Kantorova I, Lupska L, Belohlavek O, Visokai V, Trubac M, Schneiderova M. Routine 18F-FDG PET Preoperative Staging of Colorectal Cancer: Comparison with Conventional Staging and Its Impact on Treatment Decision Making. J Nucl Med 2003;44:1784-8. (Level III evidence)
  13. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of Hepatic Metastases from Cancers of the Gastrointestinal Tract by Using Noninvasive Imaging Methods (US, CT, MR Imaging, PET): A Meta-Analysis. Radiology 2002;224:748-56. (Level III evidence)
  14. Caturelli E, Solmi L, Anti M, et al. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut 2004;53:1356-62. (Level II study). Click here to view reference
  15. Chang S, Kim SH, Lim HK, Lee WJ, Choi D, Lim JH. Needle Tract Implantation After Sonographically Guided Percutaneous Biopsy of Hepatocellular Carcinoma: Evaluation of Doubling Time, Frequency, and Features on CT. AJR Am J Roentgenol 2005; 185:400-405. (Level III evidence)
  16. Federle MP, Filly RA, Moss AA. Cystic hepatic neoplasms: complementary roles of CT and sonography. AJR 1981; 136:345-348. (Level III evidence)
  17. Taboury J, Porcel A, Tubiana JM, Monnier JP. Cavernous haemangiomas of the liver studied by US. Radiology 1983; 149:781-785. (Level III evidence)
  18. Harvey CJ, ALbrecht T. Ultrasound of focal liver lesions. Eur Radiol 2001; 11:1578-1593. (Review article)
  19. Ebara M, Ohto M, Shinagawa T et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients.Gastroenterology 1986; 90:289-298. (Level III evidence)
  20. Gambarin-Gelwan M, David CD, Shapiro R, Schwartz ME, Min AD. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J gastroeneterol 2000; 95:1535-1538. (Level III evidence)
  21. Klein D, Jenett M, Gassel HJ et al. Quantitative dynamic contrast-enhanced sonography of hepatic tumours. Eur Radiol 2004; 14:1082-1091. (Level III evidence)
  22. Schillaci O, Danieli R, Manni C, Capoccetti F, Simonetti G. Technetium-99m-labelled red blood cell imaging in the diagnosis of hepatic haemangiomas: the role of SPECT/CT with a hybrid camera. Eur J Nucl Med Mol Imaging 2004; 34:1011-1015. (Level III evidence)
  23. Nguyen MH, Keeffe EB. Screening for Hepatocellular Carcinoma. J Clin Gastroenterol 2002;35 (Suppl 2):S86-91. (Review article)
  24. Wun YT , Dickinson JA. Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B. The Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD002799. DOI: 10.1002/14651858.CD002799. This version first published online: 22 April 2003 in Issue 2, 2003.
  25. Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003;52(S3):1-8. (Practice Guidelines). Click here to view reference
  26. Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Prospective Study of a-Fetoprotein in Cirrhotic Patients Monitored for Development of Hepatocellular Carcinoma. Hepatology 1994;19:61-66. (Level III evidence)
  27. Ruelas-Villavicencio AL, Vargas-Vorackova F. In whom, how and how often is surveillance for hepatocellular carcinoma cost-effective? Ann Hepatol 2004; 3:152-159. (Level II evidence) Click here to view reference
  28. Trevisani F, D'Intino PE, Morselli-Labate AM et al. Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001; 34:570-575. (Level II evidence)
  29. Sherman M. Alphafetoprotein: an obituary. J Hepatol 2001; 34:603-605. (Review article) Click here to view reference
  30. Cillo U, Bassanello M, Vitale A. The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol 2004;40:124-31. (Level III evidence)
  31. Llovet JM, Fuster J, Bruix J. Prognosis of Hepatocellular Carcinoma. Hepato-Gastroenterology 2002;49:7-11. (Level III evidence)
  32. Bruix J, Sherman M. AASLD Practice Guidelines. Management of Hepatocellular Carcinoma: An Update [document on the Internet]. The American Association for the Study of Liver Diseases; [updated 2010 July; cited 2010 Dec]. Available from: http://www.aasld.org/practiceguidelines/Pages/SortablePracticeGuidelinesAlpha.aspx. (Practice Guidelines) Click here to view reference
  33. Sangiovanni A, Manini MA, Iavarone M, Romeo R, Forzenigo LV, Fraquelli M, Massironi S, et al. The diagnostic and economic impact of contrast imaging technique in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 2010;59:570-571. (Level II evidence)
  34. Forner A, Vilana R, Ayuso C, Bianchi L, Sole M, Ayuso JR, Boix L, et al.Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008;47:97-104.(Level II evidence)
  35. Silva MA, Hegab B, Hyde C, Guo B, Buckels JA, Mirza DF. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut. 2008;57(11):1592-6. (Level II) Click here to view reference
  36. Chhieng DC. Fine needle aspiration biopsy of liver - an update. World J Surg Oncol. 2004;2:5. (Review)
  37. Durand F, Belghiti J, Paradis V. Liver transplantation for hepatocellular carcinoma: role of biopsy. Liver Transpl. 2007;13(Suppl 2):S17-23. (Review)
  38. Maturen KE, Nghiem HV, Marrero JA, Hussain HK, Higgins EG, Fox GA, Francis IR. Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique. AJR Am J Roentgenol. 2006;187(5):1184-7. (Level VI)

File Formats

Some documents for download on this website are in a Portable Document Format (PDF). To read these files you may need to download Adobe® Acrobat Reader.

GetReader

Legal Matters